GH Pitié Salpêtrière
Welcome,         Profile    Billing    Logout  
 15 Trials 
27 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DEHAIS, Caroline
StrateGlio, NCT03663725 / 2018-000410-38: Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Recruiting
3
486
Europe
Intensified protocol, Stupp protocol
Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital
Glioblastoma
05/25
11/27
POLCA, NCT02444000: gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas

Active, not recruiting
3
280
Europe
PCV chemotherapy alone, Radiotherapy+PCV chemotherapy
Assistance Publique - Hôpitaux de Paris, Association de Neuro-Oncologues d'Expression Francaise
Anaplastic Gliomas With 1p/19q Codeletion
09/24
09/24
POLO, NCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Recruiting
3
280
Europe
PCV chemotherapy, Radiotherapy and PCV chemotherapy
Hospices Civils de Lyon
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion
12/30
12/30
AGIR, NCT03666559 / 2016-002822-35: Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation

Active, not recruiting
2
8
Europe
Azacitidine, Vidaza
Assistance Publique - Hôpitaux de Paris
Recurrent IDH1/2 Mutated Glioma
02/23
03/24
Fossati, Philippe
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Recruiting
3
568
Europe, Canada, US, RoW
Psilocybin, COMP360
COMPASS Pathways
Treatment Resistant Depression
03/25
05/25
NCT03870776: RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode

Active, not recruiting
2
110
Europe
MAP4343, Placebo
Mapreg, Eurofins Optimed
Depression
12/24
03/25
NEURORELAX, NCT04545359: Study on Neurofeedback and Relaxation

Recruiting
N/A
60
Europe
Alpha-based neurofeedback, Sham neurofeedback
Centre National de la Recherche Scientifique, France, Sorbonne University, Institut du Cerveau et de la Moelle Epinière, myBrain Technologies, Institut National de la Santé Et de la Recherche Médicale, France
Healthy People
09/21
09/21
KETABELIEF, NCT05577247: Belief Updating in Treatment Resistant Depression

Recruiting
N/A
60
Europe
functional magnetic resonance imaging
Assistance Publique - Hôpitaux de Paris
Treatment Resistant Depression
02/25
02/25
STRATIDEP, NCT05866575: Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Recruiting
N/A
136
Europe
escitalopram, vortioxetine
Centre Hospitalier St Anne
Major Depressive Disorder
10/26
11/26
BOURG, Véronique
TOXSIALO, NCT03616067 / 2021-000095-10: Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

Recruiting
3
130
Europe
Botox® injection, Scopoderm® patches arm
Hospices Civils de Lyon
Cerebral Palsy
04/26
08/27
StrateGlio, NCT03663725 / 2018-000410-38: Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Recruiting
3
486
Europe
Intensified protocol, Stupp protocol
Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital
Glioblastoma
05/25
11/27
POLO, NCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Recruiting
3
280
Europe
PCV chemotherapy, Radiotherapy and PCV chemotherapy
Hospices Civils de Lyon
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion
12/30
12/30
PersoMed-I, NCT04402073 / 2020-003063-26: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Active, not recruiting
2
20
Europe, RoW
Sonidegib, Cisplatin, Lomustine, Vincristine, radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC, EORTC-BTG, Sunpharmaceuticals
Medulloblastoma
04/25
04/25
PREGENE PC, NCT05317234: Genetic Predisposition in Cerebral Palsy

Recruiting
N/A
250
Europe
Whole-exome sequencing
Hospices Civils de Lyon
Cerebral Palsy
03/28
03/28
Morélot-Panzini, Capucine
VAL-HEPHAI, NCT06099145: Clinical and Medico-economic Validation of the HEPHAI Solution.

Recruiting
N/A
238
Europe
Hephaï
Hephai
Asthma COPD
09/24
09/24
HIGHOXFILD, NCT06617078: Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild

Not yet recruiting
N/A
42
NA
long-term oxygen therapy (LTOT), High Flow Nasal Therapy (HFNT)
Assistance Publique - Hôpitaux de Paris
ILD
10/26
10/26
BACHET, Jean Baptiste
NCT04894123 / 2020-004636-25: Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients

Terminated
2
1
Europe
Trifluridine/Tipiracil, Lonsurf, Oxaliplatin, Eloxatin
GERCOR - Multidisciplinary Oncology Cooperative Group, Servier
Colorectal Adenocarcinoma, Oesogastric
02/23
02/23
MAZEPPA, NCT04348045: Personalized Maintenance Therapy for m-PDAC Using Olaparib or Selumetinib + Durvalumab, Based on BRCAness and KRAS Status.

Active, not recruiting
2
307
Europe
Arm A - Olaparib, AZD-2281, ARM B - durvalumab plus selumetinib, MEDI-4736 plus AZD-6244, ARM C FOLFIRI, folinic acid, fluorouracil, and irinotecan
GERCOR - Multidisciplinary Oncology Cooperative Group, AstraZeneca
Metastatic Pancreatic Adenocarcinoma
07/23
12/24
LONGBOARD, NCT04166604: LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

Active, not recruiting
2
176
Europe
Trifluridine/Tipiracil, Lonsurf
GERCOR - Multidisciplinary Oncology Cooperative Group
Metastatic Colorectal Cancer
11/23
11/24
TEDOPAM, NCT03806309: Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting
2
106
Europe
FOLFIRI, Leucovorin (Folinic Acid), Fluorouracil, Irinotecan, OSE2101, Tedopi
GERCOR - Multidisciplinary Oncology Cooperative Group, OSE Immunotherapeutics
Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer
12/23
12/24
NCT02979483: Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Active, not recruiting
N/A
110
Europe
14-EISCP
GERCOR - Multidisciplinary Oncology Cooperative Group
Pancreas, Management Supportive Care Program
07/22
04/25
AMPULLOMA, NCT03800212: Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma

Recruiting
N/A
402
Europe
treatment for ampullary adenocarcinoma, no other intervention name to add
Federation Francophone de Cancerologie Digestive
Ampullary Adenocarcinoma
12/22
12/22
TARGETMONITO, NCT05443087: TARGETed Therapy Drug MONITOring in DIGestive Oncology

Recruiting
N/A
330
Europe
Blood sampling to build population pharmacokinetics model
UNICANCER
Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma, GIST, Neuroendocrine Tumors
08/26
06/27
ACUPOX, NCT05850130: Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients

Recruiting
N/A
182
Europe
Acupuncture intervention, No acupuncture
GERCOR - Multidisciplinary Oncology Cooperative Group
Colorectal Cancer, Liver Cancer, Gastric Cancer, Pancreas Cancer, Esophagus Cancer
10/26
12/27
NCT04935853: Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Recruiting
N/A
1350
Europe
GERCOR - Multidisciplinary Oncology Cooperative Group
Biliary Tract Cancer
06/30
06/40
Potet, Alexia
HEMIANOTACS, NCT04043689: Therapeutic Effects of Transcranial Alternative Current Stimulation (tACS) in Chronic Post Stroke Hemianopia

Recruiting
N/A
36
Europe
tACS (transcranial Alternate Current Stimulation)
Assistance Publique - Hôpitaux de Paris
Hemianopsia
02/25
02/25
Marois, Clémence
STRESSréa, NCT06308835: Prevalence and Risk Factor of Post-intensive Care Syndrome in Neuro-ICU

Not yet recruiting
N/A
100
Europe
questionnaires
Assistance Publique - Hôpitaux de Paris
Post Intensive Care Syndrome
08/25
08/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DEHAIS, Caroline
StrateGlio, NCT03663725 / 2018-000410-38: Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Recruiting
3
486
Europe
Intensified protocol, Stupp protocol
Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital
Glioblastoma
05/25
11/27
POLCA, NCT02444000: gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas

Active, not recruiting
3
280
Europe
PCV chemotherapy alone, Radiotherapy+PCV chemotherapy
Assistance Publique - Hôpitaux de Paris, Association de Neuro-Oncologues d'Expression Francaise
Anaplastic Gliomas With 1p/19q Codeletion
09/24
09/24
POLO, NCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Recruiting
3
280
Europe
PCV chemotherapy, Radiotherapy and PCV chemotherapy
Hospices Civils de Lyon
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion
12/30
12/30
AGIR, NCT03666559 / 2016-002822-35: Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation

Active, not recruiting
2
8
Europe
Azacitidine, Vidaza
Assistance Publique - Hôpitaux de Paris
Recurrent IDH1/2 Mutated Glioma
02/23
03/24
Fossati, Philippe
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Recruiting
3
568
Europe, Canada, US, RoW
Psilocybin, COMP360
COMPASS Pathways
Treatment Resistant Depression
03/25
05/25
NCT03870776: RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode

Active, not recruiting
2
110
Europe
MAP4343, Placebo
Mapreg, Eurofins Optimed
Depression
12/24
03/25
NEURORELAX, NCT04545359: Study on Neurofeedback and Relaxation

Recruiting
N/A
60
Europe
Alpha-based neurofeedback, Sham neurofeedback
Centre National de la Recherche Scientifique, France, Sorbonne University, Institut du Cerveau et de la Moelle Epinière, myBrain Technologies, Institut National de la Santé Et de la Recherche Médicale, France
Healthy People
09/21
09/21
KETABELIEF, NCT05577247: Belief Updating in Treatment Resistant Depression

Recruiting
N/A
60
Europe
functional magnetic resonance imaging
Assistance Publique - Hôpitaux de Paris
Treatment Resistant Depression
02/25
02/25
STRATIDEP, NCT05866575: Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Recruiting
N/A
136
Europe
escitalopram, vortioxetine
Centre Hospitalier St Anne
Major Depressive Disorder
10/26
11/26
BOURG, Véronique
TOXSIALO, NCT03616067 / 2021-000095-10: Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

Recruiting
3
130
Europe
Botox® injection, Scopoderm® patches arm
Hospices Civils de Lyon
Cerebral Palsy
04/26
08/27
StrateGlio, NCT03663725 / 2018-000410-38: Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Recruiting
3
486
Europe
Intensified protocol, Stupp protocol
Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital
Glioblastoma
05/25
11/27
POLO, NCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Recruiting
3
280
Europe
PCV chemotherapy, Radiotherapy and PCV chemotherapy
Hospices Civils de Lyon
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion
12/30
12/30
PersoMed-I, NCT04402073 / 2020-003063-26: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Active, not recruiting
2
20
Europe, RoW
Sonidegib, Cisplatin, Lomustine, Vincristine, radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC, EORTC-BTG, Sunpharmaceuticals
Medulloblastoma
04/25
04/25
PREGENE PC, NCT05317234: Genetic Predisposition in Cerebral Palsy

Recruiting
N/A
250
Europe
Whole-exome sequencing
Hospices Civils de Lyon
Cerebral Palsy
03/28
03/28
Morélot-Panzini, Capucine
VAL-HEPHAI, NCT06099145: Clinical and Medico-economic Validation of the HEPHAI Solution.

Recruiting
N/A
238
Europe
Hephaï
Hephai
Asthma COPD
09/24
09/24
HIGHOXFILD, NCT06617078: Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild

Not yet recruiting
N/A
42
NA
long-term oxygen therapy (LTOT), High Flow Nasal Therapy (HFNT)
Assistance Publique - Hôpitaux de Paris
ILD
10/26
10/26
BACHET, Jean Baptiste
NCT04894123 / 2020-004636-25: Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients

Terminated
2
1
Europe
Trifluridine/Tipiracil, Lonsurf, Oxaliplatin, Eloxatin
GERCOR - Multidisciplinary Oncology Cooperative Group, Servier
Colorectal Adenocarcinoma, Oesogastric
02/23
02/23
MAZEPPA, NCT04348045: Personalized Maintenance Therapy for m-PDAC Using Olaparib or Selumetinib + Durvalumab, Based on BRCAness and KRAS Status.

Active, not recruiting
2
307
Europe
Arm A - Olaparib, AZD-2281, ARM B - durvalumab plus selumetinib, MEDI-4736 plus AZD-6244, ARM C FOLFIRI, folinic acid, fluorouracil, and irinotecan
GERCOR - Multidisciplinary Oncology Cooperative Group, AstraZeneca
Metastatic Pancreatic Adenocarcinoma
07/23
12/24
LONGBOARD, NCT04166604: LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

Active, not recruiting
2
176
Europe
Trifluridine/Tipiracil, Lonsurf
GERCOR - Multidisciplinary Oncology Cooperative Group
Metastatic Colorectal Cancer
11/23
11/24
TEDOPAM, NCT03806309: Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting
2
106
Europe
FOLFIRI, Leucovorin (Folinic Acid), Fluorouracil, Irinotecan, OSE2101, Tedopi
GERCOR - Multidisciplinary Oncology Cooperative Group, OSE Immunotherapeutics
Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer
12/23
12/24
NCT02979483: Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Active, not recruiting
N/A
110
Europe
14-EISCP
GERCOR - Multidisciplinary Oncology Cooperative Group
Pancreas, Management Supportive Care Program
07/22
04/25
AMPULLOMA, NCT03800212: Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma

Recruiting
N/A
402
Europe
treatment for ampullary adenocarcinoma, no other intervention name to add
Federation Francophone de Cancerologie Digestive
Ampullary Adenocarcinoma
12/22
12/22
TARGETMONITO, NCT05443087: TARGETed Therapy Drug MONITOring in DIGestive Oncology

Recruiting
N/A
330
Europe
Blood sampling to build population pharmacokinetics model
UNICANCER
Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma, GIST, Neuroendocrine Tumors
08/26
06/27
ACUPOX, NCT05850130: Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients

Recruiting
N/A
182
Europe
Acupuncture intervention, No acupuncture
GERCOR - Multidisciplinary Oncology Cooperative Group
Colorectal Cancer, Liver Cancer, Gastric Cancer, Pancreas Cancer, Esophagus Cancer
10/26
12/27
NCT04935853: Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Recruiting
N/A
1350
Europe
GERCOR - Multidisciplinary Oncology Cooperative Group
Biliary Tract Cancer
06/30
06/40
Potet, Alexia
HEMIANOTACS, NCT04043689: Therapeutic Effects of Transcranial Alternative Current Stimulation (tACS) in Chronic Post Stroke Hemianopia

Recruiting
N/A
36
Europe
tACS (transcranial Alternate Current Stimulation)
Assistance Publique - Hôpitaux de Paris
Hemianopsia
02/25
02/25
Marois, Clémence
STRESSréa, NCT06308835: Prevalence and Risk Factor of Post-intensive Care Syndrome in Neuro-ICU

Not yet recruiting
N/A
100
Europe
questionnaires
Assistance Publique - Hôpitaux de Paris
Post Intensive Care Syndrome
08/25
08/25

Download Options